Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.180
-0.050 (-4.07%)
At close: Jul 28, 2026, 4:00 PM EDT
1.180
0.00 (0.00%)
Pre-market: Jul 29, 2026, 6:22 AM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $81.15 million as of July 29, 2026. Its market cap has increased by 20.07% in one year.
Market Cap
81.15M
Enterprise Value
76.14M
1-Year Change
20.07%
Ranking
Category
Stock Price
$1.18
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $81.15M, a decrease of -60.85%. That is a compound annual growth rate of -31.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 81.15M | 77.48% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 84.67M |
| NeurAxis | 84.46M |
| Adicet Bio | 83.38M |
| OKYO Pharma | 81.61M |
| Inovio Pharmaceuticals | 81.38M |
| MAIA Biotechnology | 79.65M |
| PolyPid | 78.61M |
| Alps Group | 78.21M |